GIFT NIFTY 24902.00 [0.35%]     DOW JONES FUTURES 40545.79 [0.78%]     NASDAQ 17990.50 [0.38%]     FTSE 100 9120.31 [-0.20%]     NIKKEI 225 41043.25 [-1.00%]     HANG SENG 25511.81 [0.49%]     SHANGHAI 3587.68 [-0.17%]     ASX 200 8146.65 [0.00]    
CIPLA↑2.46% [37.6]     SAMMAANCAP↑1.80% [2.28]     HEROMOTOCO↑1.60% [67.3]     GRASIM↑1.55% [41.9]     BPCL↑1.51% [5]     LTF↑1.45% [2.96]     KOTAKBANK↓-6.39% [-135.6]     WIPRO↓-2.42% [-6.25]     TITAN↓-1.21% [-41.8]     BHARTIARTL↓-1.03% [-19.9]     TCS↓-1.01% [-31.4]     UNITDSPR ↓-0.75% [-24.1]    

Latest Stock Market News

Alphabet shares rose more than 3% in early trading on Thursday as the Google parent s earnings underscored a key message to investors: AI spending is climbing, but so are the returns.

Rate this item

(1 Vote)

The European Central Bank held interest rates steady Thursday as policymakers waited to see whether the eurozone would be hit by higher US tariffs threatened by President Donald Trump.

Rate this item

(1 Vote)

Tesla s shares plummeted by 8% amid concerns over declining EV sales and delayed autonomous driving advancements. CEO Elon Musk s robotaxi rollout faces regulatory hurdles, particularly in California, despite promises of widespread U.S. availability. Investors express skepticism, citing sales declines and unmet promises, questioning Tesla s growth trajectory and lofty valuation.

Cipla s June quarter earnings are anticipated to reveal a mixed performance, with robust India sales partially offsetting challenges in the US generics market. Revenue is expected to increase, while EBITDA margins may decline due to lower US contributions. Investor attention will be directed towards the US business trajectory, pricing dynamics, and the resurgence of India s trade generics segment.

India s residential property market shows signs of recovery with a 1% YoY sales volume increase in June 2025, ending a year-long decline. Sales value surged 23% driven by larger deals and improved confidence. Delhi-NCR leads the rebound, while western markets face contraction. New launches are up in select cities, but overall volumes remain challenged.

Market expert Nischal Maheshwari suggests caution regarding the IT sector due to macroeconomic uncertainties. He prefers stock-specific approaches for mid and small-cap IT companies. Within pharma, CRAMS is favored due to its China-plus-one strategy. A strong resurgence is anticipated in the consumer sector s second half, driven by positive macroeconomic factors. Investors should remain patient and invested in the consumer sector.

Rate this item

(1 Vote)

GNG Electronics’ IPO saw strong demand, subscribed 15.11 times by Day 2. Retail and NII participation was robust, and GMP indicates a 42% listing premium. The company, India’s top refurbisher, posted strong growth with a 46% revenue CAGR. Brokerages recommend subscribing, citing scale, market leadership, and formalisation trends.

Rate this item

(1 Vote)

Tata Motors shares experienced a surge, driven by optimism surrounding potential global trade deals that could lower automobile export tariffs. The US-Japan agreement, reducing tariffs on Japanese car exports, fueled speculation of similar pacts with the EU.

Rate this item

(1 Vote)

Executive Centre India is preparing to launch its IPO. The company has filed its draft prospectus with SEBI. The IPO includes a fresh issue of shares worth up to Rs 2,600 crore. The funds will be used for investment and general corporate purposes. The company provides premium flexible workspace solutions. It operates in India, Singapore, and the Middle East.

Nestle India s shares plummeted following a 13.4% YoY drop in profit after tax for Q1FY26, reaching Rs 647 crore. Elevated commodity prices and rising operational costs impacted profitability. Despite this, revenue from operations increased by 6% to Rs 5,096 crore, with domestic sales climbing 5.5%.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.